TOGO Meditech Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Series B1
- (Cancelled)
- Latest Deal Amount
-
$27.8M
- Investors
-
3
TOGO Meditech General Information
Description
Developer of medical devices, new biological materials, drugs and other products designed for bioartificial livers. The company has the ability to produce standard human hepatoblasts in medium-scale batches, and has established a large-scale GMP standard culture system.
Contact Information
Website
www.whtogo.comCorporate Office
- 5th Floor, Building C4, Bio City
- No. 666 Gaoxin Avenue, East Lake High-tech Development Zone
- Wuhan, Hubei 430000
- China
Corporate Office
- 5th Floor, Building C4, Bio City
- No. 666 Gaoxin Avenue, East Lake High-tech Development Zone
- Wuhan, Hubei 430000
- China
TOGO Meditech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B1) | 03-Nov-2022 | $27.8M | Cancelled | Generating Revenue | ||
| 3. Later Stage VC (Series B) | 29-Jul-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 01-Sep-2018 | $2.92M | $5.21M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 04-Mar-2016 | $2.29M | $2.29M | Completed | Generating Revenue |
TOGO Meditech Patents
TOGO Meditech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10485916-B2 | Bioartificial liver device | Active | 29-Jul-2016 | ||
| US-20180117236-A1 | Bioartificial liver device | Active | 29-Jul-2016 | ||
| WO-2018018792-A1 | Four-in-one on-line monitoring and constant-temperature heating integrated system of plush type for bioartificial liver | Inactive | 29-Jul-2016 | ||
| US-10493195-B2 | Integrated on-line monitoring and thermostatic heating apparatus for bioartificial liver device | Active | 29-Jul-2016 | ||
| US-20180117235-A1 | Integrated on-line monitoring and thermostatic heating apparatus for bioartificial liver device | Active | 29-Jul-2016 | A61M1/3489 |
TOGO Meditech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TopoScend Capital | Growth/Expansion | Minority | ||
| Holley Group | Corporation | Minority | ||
| Yili Capital | Growth/Expansion | Minority |
TOGO Meditech FAQs
-
When was TOGO Meditech founded?
TOGO Meditech was founded in 2013.
-
Where is TOGO Meditech headquartered?
TOGO Meditech is headquartered in Wuhan, China.
-
What industry is TOGO Meditech in?
TOGO Meditech’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is TOGO Meditech a private or public company?
TOGO Meditech is a Private company.
-
What is TOGO Meditech’s current revenue?
The current revenue for TOGO Meditech is .
-
How much funding has TOGO Meditech raised over time?
TOGO Meditech has raised $14.1M.
-
Who are TOGO Meditech’s investors?
TopoScend Capital, Holley Group, and Yili Capital have invested in TOGO Meditech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process